Investor Database — 54,000+ VC, PE & angel contacts, the full list for $19.Get the list

Yonjin Capital

Venture Capital Massachusetts, United States ·Founded 2016

Overview

Yonjin Capital is a prominent international investment firm specializing in early- and mid-stage life science companies, focusing on therapeutics, diagnostics, and medical devices. The firm operates as the North America and Europe investment arm of Yonjin Group, a China-based conglomerate headquartered in Shanghai, and is the sister firm of Yonghua Capital. With a team possessing extensive global knowledge and networks, Yonjin Capital aims to help portfolio companies achieve remarkable results. Established in 2016, Yonjin Capital is headquartered in Cambridge, Massachusetts, United States. The firm invests in innovative biotech companies seeking to advance new technologies in healthcare and life sciences. Its portfolio includes companies like Rapafusyn Pharmaceuticals, which closed an over-subscribed $44 million Series A financing round in September 2025, with Yonjin Capital participating alongside other investors. Yonjin Capital's investment strategy emphasizes long-term partnerships, deep operational engagement, and honoring the core values of businesses while preparing them for future growth. The firm's guiding principles include principled equity, acquired genius, radical collaboration, and abundant prosperity, aiming to create value that benefits every stakeholder involved.

Investment Focus

Innovative technologies in therapeutics, diagnostics, and medical devices
Early- and mid-stage life science companies
Potential for significant growth and impact in healthcare and life sciences

Portfolio Companies

Rapafusyn Pharmaceuticals

Reach Yonjin Capital directly

Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.

Unlock full contacts →

Frequently asked questions about Yonjin Capital

What sectors does Yonjin Capital invest in?

Yonjin Capital invests in Healthcare, Medical Devices, Diagnostics, Biotechnology and Therapeutics, and is based in Massachusetts, United States. Yonjin Capital is listed as a venture capital in the ConnectSafely investor database.